Estrogen Study Provides New Impetus For Development Of Colon Cancer Drugs
Tue, 19 Dec 2006 04:00 AM EST
... Estrogen may hold important clues for scientists working on new therapies for colon cancer, a study by Dana-Farber Cancer Institute researchers suggests. The investigators found that postmenopausal women with colon cancer lived longer and had less likelihood of dying of the disease if they had been taking estrogen supplements within five years of their diagnosis. The researchers stress that these findings do not mean estrogen should be viewed as a treatment or preventive therapy. ...

Not Signed In -


